ALG6

ALG6 Alpha-1,3-Glucosyltransferase

Gene Information Card

Symbol ALG6
Full Name ALG6 alpha-1,3-glucosyltransferase
Gene Type protein-coding
Chromosomal Location 1p31.1
NCBI Gene ID 29929 ncbi.nlm.nih.gov/gene/29929
Ensembl ID ENSG00000188021
UniProt ID Q9Y672
OMIM ID 604566
HGNC ID 23157
Aliases CDG1C, ALG6, glucosyltransferase I, dolichyl-P-Glc:Man9GlcNAc2-PP-dolichol alpha-1,3-glucosyltransferase

Description

The ALG6 gene encodes alpha-1,3-glucosyltransferase, an enzyme localized in the endoplasmic reticulum that catalyzes the addition of the first glucose residue to the lipid-linked oligosaccharide (LLO) precursor Man9GlcNAc2-PP-dolichol during N-linked protein glycosylation. This step is essential for proper folding and quality control of glycoproteins. Mutations in ALG6 cause congenital disorder of glycosylation type Ic (ALG6-CDG), a multisystem disorder characterized by developmental delay, hypotonia, seizures, and coagulopathy.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Congenital disorder of glycosylation type Ic (ALG6-CDG) Loss-of-function mutations in ALG6 impair the addition of the first glucose to the LLO, leading to underglycosylation of multiple glycoproteins. OMIM #603147; ClinVar; multiple case reports
Intellectual disability (non-syndromic) ALG6 variants may contribute to neurodevelopmental phenotypes through altered glycosylation of neuronal proteins. ClinVar; literature association studies

Expression Profile

Tissue Expression
Tissue nTPM level
Liver 12.5 Medium
Brain 8.3 Low
Kidney 10.1 Medium
Heart 7.4 Low
Pancreas 6.9 Low
Cell Line Expression
Cell Line nTPM Notes
HepG2 14.2 Hepatocellular carcinoma cell line
K562 9.8 Chronic myelogenous leukemia
HeLa 11.5 Cervical adenocarcinoma
A549 8.1 Lung carcinoma
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.998C>T (p.Ala333Val) Missense Common in ALG6-CDG Reduced enzymatic activity; impaired glucose transfer
c.391T>C (p.Tyr131His) Missense Rare Loss of function; associated with CDG
c.1132C>T (p.Arg378Cys) Missense Rare Decreased protein stability and activity
c.1287+1G>A Splice donor Rare Splicing defect; loss of function
Mutation functional classification

Loss of Function (LOF)

Most ALG6 mutations are loss-of-function, reducing or abolishing glucosyltransferase activity, leading to incomplete LLO assembly and N-glycosylation defects.

Gain of Function (GOF)

No gain-of-function mutations reported.

Dominant Negative (DN)

No dominant-negative effects described; ALG6-CDG is autosomal recessive.

Gene Ontology (GO)

• GO:0006487 – protein N-linked glycosylation • GO:0004578 – dolichyl-diphosphooligosaccharide-protein glycotransferase activity
• GO:0005789 – endoplasmic reticulum membrane • GO:0016757 – transferase activity
• transferring glycosyl groups • GO:0006486 – protein glycosylation

Pathways

N-glycan biosynthesis (KEGG: hsa00510)
Dolichol-linked oligosaccharide biosynthesis (Reactome: R-HSA-446193)

Protein Summary

ALG6 is a 507-amino acid transmembrane protein localized to the endoplasmic reticulum. It belongs to the glycosyltransferase family 57 and catalyzes the transfer of glucose from dolichyl-phosphate-glucose to Man9GlcNAc2-PP-dolichol, forming Glc1Man9GlcNAc2-PP-dolichol. This step is critical for the proper assembly of the oligosaccharide precursor required for N-glycosylation. Deficiency leads to accumulation of truncated LLO and hypoglycosylation of secretory and membrane proteins.

Related Products

Product name Cat.No. Species Gene ID
ALG6 Knockout HEK293 Cell Line EDJ-KQ9087 Human 29929 Details Get a Quote
ALG6 Knockout A-549 Cell Line EDJ-KQ35584 Human 29929 Details Get a Quote
ALG6 Knockout HCT 116 Cell Line EDJ-KQ35585 Human 29929 Details Get a Quote
ALG6 Knockout HeLa Cell Line EDJ-KQ35586 Human 29929 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: